The treatment of renal carcinoma

The treatment of renal cell carcinoma with CyberKnife^® offers several advantages. First, precise radiotherapy allows for higher dose delivery to the tumor, resulting in more effective tumor destruction. Second, the treatment is non-invasive, meaning no surgery is required. This reduces the risk of complications and significantly reduces recovery time. Third, CyberKnife^® enables a shorter treatment time compared to conventional radiation methods. In most cases, only a few sessions are required, usually within a week or two. The treatment of renal cell carcinoma with CyberKnife^® usually takes place in a series of outpatient sessions. Before starting treatment, detailed diagnostic imaging is performed to determine the exact location of the tumor. This enables the beam of rays to be precisely aimed at the tumor during treatment. During the session, the patient lies on a special treatment table connected to the CyberKnife^® system. The robotic arm of the CyberKnife^® system moves precisely around the patient to direct the beam of radiation onto the tumor from different angles. The patient usually does not feel any pain during the treatment.

However, it should be noted that the decision to undergo treatment with CyberKnife^® for renal cell carcinoma depends on various factors. It is important that patients consult with a radiotherapy specialist to receive a comprehensive assessment of their individual case and determine the best possible treatment option.